Anton Kiselev

1.5k total citations
64 papers, 1.2k citations indexed

About

Anton Kiselev is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Anton Kiselev has authored 64 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 20 papers in Genetics and 20 papers in Genetics. Recurrent topics in Anton Kiselev's work include RNA Interference and Gene Delivery (29 papers), Virus-based gene therapy research (17 papers) and Neurogenetic and Muscular Disorders Research (17 papers). Anton Kiselev is often cited by papers focused on RNA Interference and Gene Delivery (29 papers), Virus-based gene therapy research (17 papers) and Neurogenetic and Muscular Disorders Research (17 papers). Anton Kiselev collaborates with scholars based in Russia, Sweden and Finland. Anton Kiselev's co-authors include N.G. Abdulaev, Yu.A. Ovchinnikov, Anna Egorova, M.Yu. Feigina, Nikolai A. Lobanov, В. С. Баранов, Marianna Maretina, S. А. Selkov, Galina Yurevna Zheleznyakova and Arto Urtti and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Anton Kiselev

64 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anton Kiselev Russia 20 862 411 183 175 149 64 1.2k
Seishi Kato Japan 19 1.3k 1.6× 209 0.5× 39 0.2× 182 1.0× 180 1.2× 44 1.8k
Alexander J. Annala United States 22 680 0.8× 180 0.4× 246 1.3× 322 1.8× 44 0.3× 30 1.6k
Eugene A. Zhukovsky United States 17 1.2k 1.4× 787 1.9× 104 0.6× 53 0.3× 488 3.3× 35 2.0k
O.J. Harrison United States 18 1.2k 1.4× 193 0.5× 43 0.2× 68 0.4× 138 0.9× 20 1.7k
Xiangduo Kong United States 20 1.3k 1.5× 63 0.2× 64 0.3× 144 0.8× 50 0.3× 35 1.7k
Margarita Gutova United States 23 974 1.1× 112 0.3× 491 2.7× 267 1.5× 153 1.0× 42 1.9k
Andreas Ettinger Germany 16 668 0.8× 88 0.2× 34 0.2× 102 0.6× 61 0.4× 23 1.2k
Ari J. Firestone United States 17 1.4k 1.6× 84 0.2× 73 0.4× 216 1.2× 183 1.2× 25 2.0k
Laird Miers United States 25 536 0.6× 179 0.4× 38 0.2× 53 0.3× 240 1.6× 41 1.9k
Gaëlle Recher France 13 649 0.8× 61 0.1× 24 0.1× 77 0.4× 90 0.6× 32 1.3k

Countries citing papers authored by Anton Kiselev

Since Specialization
Citations

This map shows the geographic impact of Anton Kiselev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Kiselev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Kiselev more than expected).

Fields of papers citing papers by Anton Kiselev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anton Kiselev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Kiselev. The network helps show where Anton Kiselev may publish in the future.

Co-authorship network of co-authors of Anton Kiselev

This figure shows the co-authorship network connecting the top 25 collaborators of Anton Kiselev. A scholar is included among the top collaborators of Anton Kiselev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anton Kiselev. Anton Kiselev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maretina, Marianna, et al.. (2024). Assessment of Nuclear Gem Quantity for Evaluating the Efficacy of Antisense Oligonucleotides in Spinal Muscular Atrophy Cells. Methods and Protocols. 7(1). 9–9. 4 indexed citations
2.
Egorova, Anna, et al.. (2023). iRGD-Targeted Peptide Nanoparticles for Anti-Angiogenic RNAi-Based Therapy of Endometriosis. Pharmaceutics. 15(8). 2108–2108. 8 indexed citations
3.
Egorova, Anna, et al.. (2023). Non-Viral Carriers for Nucleic Acids Delivery: Fundamentals and Current Applications. Life. 13(4). 903–903. 20 indexed citations
4.
Egorova, Anna, et al.. (2022). Amphiphilic pH-sensitive polypeptides for siRNA delivery. Journal of Drug Delivery Science and Technology. 69. 103135–103135. 17 indexed citations
5.
Maretina, Marianna, K. R. Valetdinova, Anna Egorova, et al.. (2021). Identification of specific gene methylation patterns during motor neuron differentiation from spinal muscular atrophy patient-derived iPSC. Gene. 811. 146109–146109. 5 indexed citations
6.
Valetdinova, K. R., Marianna Maretina, Yuri V. Vyatkin, et al.. (2020). Generation of three Duchenne muscular dystrophy patient-derived induced pluripotent stem cell (iPSC) lines ICGi002-A, ICGi002-B and ICGi002-C. Stem Cell Research. 48. 101941–101941. 2 indexed citations
7.
Valetdinova, K. R., Marianna Maretina, Е. В. Григорьева, et al.. (2019). Generation of two spinal muscular atrophy (SMA) type I patient-derived induced pluripotent stem cell (iPSC) lines and two SMA type II patient-derived iPSC lines. Stem Cell Research. 34. 101376–101376. 12 indexed citations
8.
9.
Egorova, Anna, et al.. (2017). Arginine-rich cross-linking peptides with different SV40 nuclear localization signal content as vectors for intranuclear DNA delivery. Bioorganic & Medicinal Chemistry Letters. 27(21). 4781–4785. 22 indexed citations
10.
Григорьева, Е. В., K. R. Valetdinova, Alexander I. Shevchenko, et al.. (2016). Neural differentiation of patient-specific induced pluripotent stem cells from patients with a hereditary form of spinal muscular atrophy. Genes and Cells. 11(2). 70–81. 4 indexed citations
11.
Egorova, Anna, et al.. (2016). CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery. International Journal of Pharmaceutics. 515(1-2). 431–440. 34 indexed citations
12.
Zheleznyakova, Galina Yurevna, Emil Nilsson, Anton Kiselev, et al.. (2015). Methylation Levels of SLC23A2 and NCOR2 Genes Correlate with Spinal Muscular Atrophy Severity. PLoS ONE. 10(3). e0121964–e0121964. 23 indexed citations
13.
Egorova, Anna & Anton Kiselev. (2015). Peptide modules for overcoming barriers of nucleic acids transport to cells. Current Topics in Medicinal Chemistry. 16(3). 330–342. 20 indexed citations
14.
Egorova, Anna, et al.. (2014). Recent Advances in Gene Therapy of Endometriosis. PubMed. 7(3). 169–178. 24 indexed citations
15.
Zheleznyakova, Galina Yurevna, Sarah Voisin, Anton Kiselev, et al.. (2013). Genome-wide analysis shows association of epigenetic changes in regulators of Rab and Rho GTPases with spinal muscular atrophy severity. European Journal of Human Genetics. 21(9). 988–993. 29 indexed citations
16.
Kiselev, Anton, Anna Egorova, Antti Laukkanen, В. С. Баранов, & Arto Urtti. (2012). Characterization of reducible peptide oligomers as carriers for gene delivery. International Journal of Pharmaceutics. 441(1-2). 736–747. 26 indexed citations
17.
Zheleznyakova, Galina Yurevna, Anton Kiselev, Mathias Rask‐Andersen, et al.. (2011). Genetic and expression studies of SMN2 gene in Russian patients with spinal muscular atrophy type II and III. BMC Medical Genetics. 12(1). 96–96. 35 indexed citations
18.
Egorova, Anna, Anton Kiselev, Marika Häkli, et al.. (2009). Chemokine‐derived peptides as carriers for gene delivery to CXCR4 expressing cells. The Journal of Gene Medicine. 11(9). 772–781. 32 indexed citations
19.
Ovchinnikov, Yuri A., et al.. (1986). Tyrosine residue catalyzes light-inducing deprotonation of retinal Schiff's base in bacteriorhodopsin. Биологические мембраны Журнал мембранной и клеточной биологии. 3(4). 325–338. 3 indexed citations
20.
Ovchinnikov, Yu.A., N.G. Abdulaev, M.Yu. Feigina, Anton Kiselev, & Nikolai A. Lobanov. (1977). Recent findings in the structure—functional characteristics of bacteriorhodopsin. FEBS Letters. 84(1). 1–4. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seishi Kato Breakdown of academic impact, for papers by Alexander J. Annala Breakdown of academic impact, for papers by Eugene A. Zhukovsky Breakdown of academic impact, for papers by O.J. Harrison Breakdown of academic impact, for papers by Xiangduo Kong Breakdown of academic impact, for papers by Margarita Gutova Breakdown of academic impact, for papers by Andreas Ettinger Breakdown of academic impact, for papers by Ari J. Firestone Breakdown of academic impact, for papers by Laird Miers Breakdown of academic impact, for papers by Gaëlle Recher
Rankless by CCL
2026